Research progress on immunotherapy in triple-negative breast cancer (Review)

Triple-negative breast cancer (TNBC) is a highly heterogeneous and aggressive malignancy. Due to the absence of estrogen receptors and progesterone receptors and the lack of overexpression of human epidermal growth factor receptor 2, TNBC responds poorly to endocrine and targeted therapies. As a neo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaoxiao, Ge, Xueying, Jiang, Tinghan, Yang, Ruming, Li, Sijie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256074/
https://www.ncbi.nlm.nih.gov/pubmed/35762339
http://dx.doi.org/10.3892/ijo.2022.5385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256074/
https://www.ncbi.nlm.nih.gov/pubmed/35762339
http://dx.doi.org/10.3892/ijo.2022.5385

Ejemplares similares